IQuity is a research organization developing the next generation of blood-based, genomic tests to detect and monitor autoimmune disease.IQuity continues to build an intellectual property portfolio focused on detecting and monitoring autoimmune disease. IQuity commercialized three genomic tests for multiple sclerosis, IBS versus Crohn's and ulcerative colitis, and fibromyalgia syndrome. IQuity has transitioned from a commercial laboratory to a pure R&D organization that continues to receive NIH/SBIR grant funding.

Diagnostics Autoimmune disease Analytics Wellness Immunology Health Family Practice Internal Medicine Neurology Gastroenterology Rheumatology Pain Management multiple sclerosis IBS DNA fibromyalgia rheumatoid arthritis lupus Crohn's ulcerative colitis Crohn's data science machine learning population risk RNA data analytics artificial intelligence predictive analytics prescriptive analytics healthcare analytics disease management chronic disease employers self-insured employers health plans Alzheimer's Crohn's Alzheimer's